Shoshana Shendelman - Aug 2, 2022 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Shoshana Shendelman
Stock symbol
APLT
Transactions as of
Aug 2, 2022
Transactions value $
$0
Form type
4
Date filed
8/4/2022, 08:40 PM
Previous filing
Jan 27, 2022
Next filing
Oct 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer -235K -100% 0 Aug 2, 2022 Common Stock 235K $3.33 Direct F1, F2
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer +235K 235K Aug 2, 2022 Common Stock 235K $1.05 Direct F1, F2
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer -102K -100% 0 Aug 2, 2022 Common Stock 102K $23.15 Direct F1, F3
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer +102K 102K Aug 2, 2022 Common Stock 102K $1.05 Direct F1, F3
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer -135K -100% 0 Aug 2, 2022 Common Stock 135K $22.20 Direct F1, F4
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer +135K 135K Aug 2, 2022 Common Stock 135K $1.05 Direct F1, F4
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer -23.3K -100% 0 Aug 2, 2022 Common Stock 23.3K $22.20 Direct F1
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer +23.3K 23.3K Aug 2, 2022 Common Stock 23.3K $1.05 Direct F1
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer -607K -100% 0 Aug 2, 2022 Common Stock 607K $10.00 Direct F1, F5
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer +607K 607K Aug 2, 2022 Common Stock 607K $1.05 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
F2 These Options are fully vested.
F3 Reflects an initial grant of 256,850 Options granted on December 10, 2020 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
F4 Reflects an initial grant of 209,000 Options granted on December 16, 2019 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 16, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
F5 Reflects an initial grant of 767,349 Options granted on May 13, 2019 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on May 13, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.